These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21947516)

  • 1. Integrative, multimodal analysis of glioblastoma using TCGA molecular data, pathology images, and clinical outcomes.
    Kong J; Cooper LA; Wang F; Gutman DA; Gao J; Chisolm C; Sharma A; Pan T; Van Meir EG; Kurc TM; Moreno CS; Saltz JH; Brat DJ
    IEEE Trans Biomed Eng; 2011 Dec; 58(12):3469-74. PubMed ID: 21947516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An anatomic transcriptional atlas of human glioblastoma.
    Puchalski RB; Shah N; Miller J; Dalley R; Nomura SR; Yoon JG; Smith KA; Lankerovich M; Bertagnolli D; Bickley K; Boe AF; Brouner K; Butler S; Caldejon S; Chapin M; Datta S; Dee N; Desta T; Dolbeare T; Dotson N; Ebbert A; Feng D; Feng X; Fisher M; Gee G; Goldy J; Gourley L; Gregor BW; Gu G; Hejazinia N; Hohmann J; Hothi P; Howard R; Joines K; Kriedberg A; Kuan L; Lau C; Lee F; Lee H; Lemon T; Long F; Mastan N; Mott E; Murthy C; Ngo K; Olson E; Reding M; Riley Z; Rosen D; Sandman D; Shapovalova N; Slaughterbeck CR; Sodt A; Stockdale G; Szafer A; Wakeman W; Wohnoutka PE; White SJ; Marsh D; Rostomily RC; Ng L; Dang C; Jones A; Keogh B; Gittleman HR; Barnholtz-Sloan JS; Cimino PJ; Uppin MS; Keene CD; Farrokhi FR; Lathia JD; Berens ME; Iavarone A; Bernard A; Lein E; Phillips JW; Rostad SW; Cobbs C; Hawrylycz MJ; Foltz GD
    Science; 2018 May; 360(6389):660-663. PubMed ID: 29748285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
    Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine-based morphologic analysis of glioblastoma using whole-slide pathology images uncovers clinically relevant molecular correlates.
    Kong J; Cooper LA; Wang F; Gao J; Teodoro G; Scarpace L; Mikkelsen T; Schniederjan MJ; Moreno CS; Saltz JH; Brat DJ
    PLoS One; 2013; 8(11):e81049. PubMed ID: 24236209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative subtype discovery in glioblastoma using iCluster.
    Shen R; Mo Q; Schultz N; Seshan VE; Olshen AB; Huse J; Ladanyi M; Sander C
    PLoS One; 2012; 7(4):e35236. PubMed ID: 22539962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrative approach for in silico glioma research.
    Cooper LA; Kong J; Gutman DA; Wang F; Cholleti SR; Pan TC; Widener PM; Sharma A; Mikkelsen T; Flanders AE; Rubin DL; Van Meir EG; Kurc TM; Moreno CS; Brat DJ; Saltz JH
    IEEE Trans Biomed Eng; 2010 Oct; 57(10):2617-21. PubMed ID: 20656651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
    Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
    Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
    Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
    Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
    Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
    BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.
    Wang S; Liu F; Wang Y; Fan W; Zhao H; Liu L; Cen C; Jiang X; Sun M; Han P
    J Transl Med; 2019 May; 17(1):179. PubMed ID: 31138312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
    Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
    EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
    Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
    J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
    Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
    PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.
    Jia D; Li S; Li D; Xue H; Yang D; Liu Y
    Aging (Albany NY); 2018 Apr; 10(4):592-605. PubMed ID: 29676997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis.
    Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K
    World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data.
    Gutman DA; Cobb J; Somanna D; Park Y; Wang F; Kurc T; Saltz JH; Brat DJ; Cooper LA
    J Am Med Inform Assoc; 2013; 20(6):1091-8. PubMed ID: 23893318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses.
    Yuan F; Yi L; Hai L; Wang Y; Yang Y; Li T; Tong L; Ma H; Liu P; Ming H; Ren B; Yu S; Lin Y; Yang X
    Dis Markers; 2019; 2019():7049294. PubMed ID: 31772693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
    Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
    J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes.
    Yang Y; More S; De Smet F; De Vleeschouwer S; Agostinis P
    Front Immunol; 2024; 15():1342977. PubMed ID: 38698847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualizing molecular profiles of glioblastoma with GBM-BioDP.
    Celiku O; Johnson S; Zhao S; Camphausen K; Shankavaram U
    PLoS One; 2014; 9(7):e101239. PubMed ID: 25010047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.